Brief: Herantis Pharma plans a directed share issue

Herantis Pharma Oyj

19/10/2017 14:00

Oct 19 (Reuters) - HERANTIS PHARMA OYJ  HRTIS.HE : 
    * PLANS A DIRECTED SHARE ISSUE TO A LIMITED NUMBER OF INVESTORS AND COMPANY'S DIRECTORS 
    * ISSUE REGARDS FINANCING OF LYMFACTIN PHASE 2 CLINICAL STUDY 
    * POSSIBLE SHARE ISSUE WOULD SEEK NEW EQUITY FINANCING IN AN AMOUNT OF APPROXIMATELY 4.6 
MILLION EUROS 
    * SHARE ISSUE OF UP TO 800,000 SHARES 
 
Source text for Eikon:  ID:nGNE2c0lht  
Further company coverage:  HRTIS.HE  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))